• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

固体结晶制剂中溶出度提高机制的见解

Insights into the Mechanism of Enhanced Dissolution in Solid Crystalline Formulations.

作者信息

Justen Anna, Schaldach Gerhard, Thommes Markus

机构信息

Laboratory of Solids Process Engineering, Department of Biochemical and Chemical Engineering, Technical University Dortmund, Emil-Figge-Straße 68, 44227 Dortmund, Germany.

出版信息

Pharmaceutics. 2024 Apr 7;16(4):510. doi: 10.3390/pharmaceutics16040510.

DOI:10.3390/pharmaceutics16040510
PMID:38675170
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11054551/
Abstract

Solid dispersions are a promising approach to enhance the dissolution of poorly water-soluble drugs. Solid crystalline formulations show a fast drug dissolution and a high thermodynamic stability. To understand the mechanisms leading to the faster dissolution of solid crystalline formulations, physical mixtures of the poorly soluble drugs celecoxib, naproxen and phenytoin were investigated in the flow through cell (apparatus 4). The effect of drug load, hydrodynamics in the flow through cell and particle size reduction in co-milled physical mixtures were studied. A carrier- and drug-enabled dissolution could be distinguished. Below a certain drug load, the limit of drug load, carrier-enabled dissolution occurred, and above this value, the drug defined the dissolution rate. For a carrier-enabled behavior, the dissolution kinetics can be divided into a first fast phase, a second slow phase and a transition phase in between. This study contributes to the understanding of the dissolution mechanism in solid crystalline formulations and is thereby valuable for the process and formulation development.

摘要

固体分散体是提高难溶性药物溶出度的一种有前景的方法。固体结晶制剂表现出快速的药物溶出和高的热力学稳定性。为了理解导致固体结晶制剂更快溶出的机制,在流通池(装置4)中研究了难溶性药物塞来昔布、萘普生和苯妥英的物理混合物。研究了药物负载量、流通池中的流体动力学以及共研磨物理混合物中粒径减小的影响。可以区分载体介导的溶出和药物介导的溶出。在一定药物负载量以下,即药物负载量极限,发生载体介导的溶出,高于该值时,药物决定溶出速率。对于载体介导的行为,溶出动力学可分为第一个快速阶段、第二个缓慢阶段以及两者之间的过渡阶段。本研究有助于理解固体结晶制剂中的溶出机制,因此对工艺和制剂开发具有重要价值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/a6ed8bad537d/pharmaceutics-16-00510-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/3d902d05e489/pharmaceutics-16-00510-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/e633723be7ed/pharmaceutics-16-00510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/7c466a9e0732/pharmaceutics-16-00510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/c8c55b26df73/pharmaceutics-16-00510-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/0091b7347c65/pharmaceutics-16-00510-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/52a08b8025d3/pharmaceutics-16-00510-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/94552d04e1dd/pharmaceutics-16-00510-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/f95a13170cec/pharmaceutics-16-00510-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/67617d99631d/pharmaceutics-16-00510-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/a6ed8bad537d/pharmaceutics-16-00510-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/3d902d05e489/pharmaceutics-16-00510-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/e633723be7ed/pharmaceutics-16-00510-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/7c466a9e0732/pharmaceutics-16-00510-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/c8c55b26df73/pharmaceutics-16-00510-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/0091b7347c65/pharmaceutics-16-00510-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/52a08b8025d3/pharmaceutics-16-00510-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/94552d04e1dd/pharmaceutics-16-00510-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/f95a13170cec/pharmaceutics-16-00510-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/67617d99631d/pharmaceutics-16-00510-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/837f/11054551/a6ed8bad537d/pharmaceutics-16-00510-g010.jpg

相似文献

1
Insights into the Mechanism of Enhanced Dissolution in Solid Crystalline Formulations.固体结晶制剂中溶出度提高机制的见解
Pharmaceutics. 2024 Apr 7;16(4):510. doi: 10.3390/pharmaceutics16040510.
2
To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.提高难溶性药物的溶出速率:盐酸氨基葡萄糖作为固体分散体制剂中的潜在载体。
Colloids Surf B Biointerfaces. 2010 Mar 1;76(1):170-8. doi: 10.1016/j.colsurfb.2009.10.030. Epub 2009 Nov 11.
3
The dissolution enhancement of piroxicam in its physical mixtures and solid dispersion formulations using gluconolactone and glucosamine hydrochloride as potential carriers.使用葡萄糖酸内酯和盐酸氨基葡萄糖作为潜在载体,吡罗昔康在其物理混合物和固体分散体配方中的溶出度增强。
Pharm Dev Technol. 2015 Jan;20(1):74-83. doi: 10.3109/10837450.2013.871029. Epub 2014 Jan 6.
4
Mechanisms of drug release from a melt-milled, poorly soluble drug substance.难溶性药物经熔融研磨后药物释放的机制
J Pharm Sci. 2025 Jan;114(1):394-401. doi: 10.1016/j.xphs.2024.10.016. Epub 2024 Oct 18.
5
Anomalous dissolution behavior of celecoxib in PVP/Isomalt solid dispersions prepared using spray drier.使用喷雾干燥机制备的塞来昔布在PVP/异麦芽酮糖醇固体分散体中的异常溶解行为。
Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:501-511. doi: 10.1016/j.msec.2016.11.042. Epub 2016 Nov 14.
6
Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.新型脂质制剂增强了难溶性模型药物吡罗昔康的体外溶出度和通透性特征。
Int J Pharm. 2005 Sep 14;301(1-2):209-16. doi: 10.1016/j.ijpharm.2005.05.032.
7
Dissolution Kinetics of Meloxicam Formulations Co-Milled with Sodium Lauryl Sulfate.美洛昔康与十二烷基硫酸钠共研磨制剂的溶出动力学
Pharmaceutics. 2022 Oct 12;14(10):2173. doi: 10.3390/pharmaceutics14102173.
8
Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance.利托那韦-共聚维酮无定形固体分散体的溶解机制研究:一致释放对于增强性能的重要性。
Mol Pharm. 2019 Mar 4;16(3):1327-1339. doi: 10.1021/acs.molpharmaceut.8b01261. Epub 2019 Feb 5.
9
Mechanism of increased dissolution of diazepam and temazepam from polyethylene glycol 6000 solid dispersions.地西泮和替马西泮在聚乙二醇6000固体分散体中溶出度增加的机制。
Int J Pharm. 2002 Dec 5;249(1-2):45-58. doi: 10.1016/s0378-5173(02)00532-x.
10
Effects of Polymers on the Drug Solubility and Dissolution Enhancement of Poorly Water-Soluble Rivaroxaban.聚合物对难溶性利伐沙班的药物溶解度和溶解增强作用的影响。
Int J Mol Sci. 2022 Aug 22;23(16):9491. doi: 10.3390/ijms23169491.

引用本文的文献

1
Development of Low-Dose Disulfiram Rectal Suppository Intended for Application in Post-Treatment Lyme Disease Syndrome.用于治疗莱姆病后综合征的低剂量双硫仑直肠栓剂的研发。
Pharmaceutics. 2025 Jun 28;17(7):849. doi: 10.3390/pharmaceutics17070849.
2
An Investigation into the Effect of Maltitol, Sorbitol, and Xylitol on the Formation of Carbamazepine Solid Dispersions Through Thermal Processing.麦芽糖醇、山梨醇和木糖醇对卡马西平热加工固体分散体形成影响的研究
Pharmaceutics. 2025 Mar 2;17(3):321. doi: 10.3390/pharmaceutics17030321.
3
Influence of Solvent Polarity on the Conformer Ratio of Bicalutamide in Saturated Solutions: Insights from NOESY NMR Analysis and Quantum-Chemical Calculations.

本文引用的文献

1
Hard Gelatin Capsules Containing Hot Melt Extruded Solid Crystal Suspension of Carbamazepine for improving dissolution: Preparation and Evaluation.含卡马西平热熔挤出固体晶体悬浮液的硬明胶胶囊用于改善溶出度:制备与评价
J Drug Deliv Sci Technol. 2023 Apr;82. doi: 10.1016/j.jddst.2023.104384. Epub 2023 Mar 21.
2
Dissolution Mechanisms of Amorphous Solid Dispersions: Role of Drug Load and Molecular Interactions.非晶态固体分散体的溶出机制:药物载量和分子相互作用的作用
Mol Pharm. 2023 Jan 2;20(1):722-737. doi: 10.1021/acs.molpharmaceut.2c00892. Epub 2022 Dec 22.
3
Melt milling as manufacturing method for solid crystalline suspensions.
溶剂极性对比卡鲁胺在饱和溶液中构象比例的影响:来自 NOESY NMR 分析和量子化学计算的见解。
Int J Mol Sci. 2024 Jul 28;25(15):8254. doi: 10.3390/ijms25158254.
熔融研磨法作为制备固态晶体混悬剂的方法。
Eur J Pharm Biopharm. 2021 Jan;158:245-253. doi: 10.1016/j.ejpb.2020.11.020. Epub 2020 Nov 27.
4
Mechanisms of increased bioavailability through amorphous solid dispersions: a review.通过无定形固体分散体增加生物利用度的机制:综述。
Drug Deliv. 2020 Dec;27(1):110-127. doi: 10.1080/10717544.2019.1704940.
5
Electrostatic Precipitation of Submicron Particles in a Molten Carrier.熔融载体中亚微米颗粒的静电沉淀
Pharmaceutics. 2019 Jun 13;11(6):276. doi: 10.3390/pharmaceutics11060276.
6
Microstructure Formation for Improved Dissolution Performance of Lopinavir Amorphous Solid Dispersions.提高洛匹那韦无定形固体分散体溶解性能的微观结构形成。
Mol Pharm. 2019 Apr 1;16(4):1751-1765. doi: 10.1021/acs.molpharmaceut.9b00117. Epub 2019 Mar 11.
7
The Influence of Polymers on the Supersaturation Potential of Poor and Good Glass Formers.聚合物对难形成玻璃和易形成玻璃物质的过饱和潜力的影响。
Pharmaceutics. 2018 Sep 21;10(4):164. doi: 10.3390/pharmaceutics10040164.
8
Solid crystal suspension of Efavirenz using hot melt extrusion: Exploring the role of crystalline polyols in improving solubility and dissolution rate.使用热熔挤出法制备的依非韦伦固体晶体悬浮液:探索结晶多元醇在提高溶解度和溶解速率中的作用。
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:1023-1034. doi: 10.1016/j.msec.2017.04.055. Epub 2017 Apr 28.
9
Glass Forming Ability of Amorphous Drugs Investigated by Continuous Cooling and Isothermal Transformation.通过连续冷却和等温转变研究非晶态药物的玻璃形成能力。
Mol Pharm. 2016 Sep 6;13(9):3318-25. doi: 10.1021/acs.molpharmaceut.6b00650. Epub 2016 Aug 26.
10
Effects of Pump Pulsation on Hydrodynamic Properties and Dissolution Profiles in Flow-Through Dissolution Systems (USP 4).泵脉动对流通式溶出系统(美国药典4)中流体动力学性质和溶出曲线的影响
Pharm Res. 2016 Jun;33(6):1327-36. doi: 10.1007/s11095-016-1874-8. Epub 2016 Feb 11.